Skip to content

Vascular Endothelial Inflammation and Health Status In INOCA (VISION-INOCA)

A Single Center Diagnostic Study of Endothelial Inflammation and Health Status in Patients With Ischemia and Nonobstructive Coronary Arteries (INOCA)

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07586241
Enrollment
250
Registered
2026-05-14
Start date
2026-05-01
Completion date
2031-03-01
Last updated
2026-05-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischemia and Non-obstructive Coronary Arteries

Keywords

INOCA

Brief summary

The purpose of this study is to evaluate coronary artery and peripheral vein vascular endothelial profiles in patients with ischemia with non-obstructive coronary arteries (INOCA) who undergo coronary function testing (CFT). The aims are: (1) Evaluate coronary artery endothelial profiles and associations with coronary microvascular dysfunction (CMD) in INOCA. (2) Assess brachial vein endothelial cell profiles in patients with INOCA and associations with CMD, and (3) Characterize relationships between endothelial signatures and anginal symptoms, functional status, and physical activity at baseline and 1-year follow-up.

Interventions

Participant will undergo invasive coronary angiography as clinically indicated (standard of care).

PROCEDURECoronary Artery Endothelial Cell Sampling

Endothelial cells will be obtained from clinical coronary guidewires after retrieval from the guide catheter.

DEVICEFitbit

Wearable activity monitoring device that measures physical activity based on the number of steps per day. The device also tracks sleep efficiency (exploratory) through a proprietary algorithm, and other health metrics. Daily step count and heart rate are recorded on the wearable device.

DIAGNOSTIC_TESTInvasive coronary function testing

Participants will undergo invasive coronary function testing as clinically indicated (standard of care).

Sponsors

NYU Langone Health
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Adult age ≥18 years referred for clinically indicated coronary angiography 2. Chronic coronary disease or potentially ischemic symptoms as the indication for coronary angiography 3. Possible or suspected ischemia with non-obstructive epicardial coronary arteries (INOCA)

Exclusion criteria

Clinical (Pre-Cath)

Design outcomes

Primary

MeasureTime frameDescription
Change in Seattle Angina Questionnaire (SAQ) scoreBaseline, 1 year follow upThe Seattle Angina Questionnaire (SAQ) scores range from 0 to 100 for all five domains (Physical Limitations, Angina Stability, Angina Frequency, Treatment Satisfaction, and Quality of Life), with higher scores indicating better health status, fewer limitations, and less frequent angina. A 10-point change in score is typically considered clinically significant.
Change in Duke Activity Status Index (DASI) scoreBaseline, 1 year follow upThe DASI is a 12-item self-report questionnaire used to assess a patient's functional capacity. Scores range from 0 to 58.2, with higher scores indicating better functional capacity.

Countries

United States

Contacts

CONTACTNathaniel Smilowitz, MD
nathaniel.smilowitz@nyulangone.org212-263-5656
CONTACTManuela Plazas Montana
inoca@nyulangone.org917-921-6436
PRINCIPAL_INVESTIGATORNathaniel Smilowitz, MD

NYU Langone Health

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 15, 2026